Literature DB >> 8878344

Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil.

L H Gold1, R L Balster.   

Abstract

Modafinil [(diphenyl-methyl)sulphinyl-2-acetamide] is a novel psychostimulant drug which is effective in the treatment of narcolepsy and idiopathic hypersomnia. It also has neuroprotective effects in animal models of striatal neuropathology. Although the cellular mechanisms of action of modafinil are poorly understood, it has been shown to have a profile of pharmacological effects that differs considerably from that of amphetamine-like stimulants. There is some evidence that modafinil has central alpha 1-adrenergic agonist effects. In the present study modafinil was evaluated for cocaine-like discriminative stimulus effects in rats and for reinforcing effects in rhesus monkeys maintained on intravenous cocaine self-administration. Modafinil, l-ephedrine and d-amphetamine all produced dose dependent increases in cocaine-lever responding, with maximal levels of 67%, 82% and 100%, respectively. Modafinil produced full substitution in four out of the six rats tested while the highest levels of substitution were associated with substantial response rate decreasing effects. Little evidence was obtained that the discriminative stimulus effects of modafinil were produced by alpha 1-adrenergic activation, based upon results of tests performed in combination with prazosin. In the self-administration procedure, modafinil and l-ephedrine functioned as reinforcers in rhesus monkeys. The reinforcing and discriminative stimulus effects of modafinil-required very high doses: modafinil was over 200 times less potent than d-amphetamine and was also less potent than l-ephedrine. These results show that modafinil has some cocaine-like discriminative stimulus effects and, like other abused stimulants, can serve as a reinforcer at high doses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878344     DOI: 10.1007/bf02247379

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Cocaethylene inhibits dopamine uptake and produces cocaine-like actions in drug discrimination studies.

Authors:  J J Woodward; R Mansbach; F I Carroll; R L Balster
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

2.  Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue.

Authors:  D V Gauvin; R D Harland; R C Michaelis; F A Holloway
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration.

Authors:  J F Hermant; F A Rambert; J Duteil
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Modafinil binds to the dopamine uptake carrier site with low affinity.

Authors:  E Mignot; S Nishino; C Guilleminault; W C Dement
Journal:  Sleep       Date:  1994-08       Impact factor: 5.849

5.  Nisoxetine and amphetamine share discriminative stimulus properties in mice.

Authors:  A M Snoddy; R E Tessel
Journal:  Pharmacol Biochem Behav       Date:  1983-08       Impact factor: 3.533

6.  The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.

Authors:  P Simon; C Panissaud; J Costentin
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

7.  Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.

Authors:  K Fuxe; A M Janson; L Rosén; U B Finnman; S Tanganelli; M Morari; M Goldstein; L F Agnati
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

8.  Intravenous buspirone self-administration in rhesus monkeys.

Authors:  R L Balster; W L Woolverton
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

9.  Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

Authors:  P M Beardsley; R L Balster; L S Harris
Journal:  Drug Alcohol Depend       Date:  1986-10       Impact factor: 4.492

10.  Factors influencing the reinforcing and subjective effects of ephedrine in humans.

Authors:  L D Chait
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more
  48 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 2.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens.

Authors:  Takuya Funayama; Yumiko Ikeda; Amane Tateno; Hidehiko Takahashi; Yoshiro Okubo; Haruhisa Fukayama; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

4.  Modafinil in sports: ethical considerations.

Authors:  K R Kaufman
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

5.  R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

Authors:  Claus J Loland; Maddalena Mereu; Oluyomi M Okunola; Jianjing Cao; Thomas E Prisinzano; Sonia Mazier; Theresa Kopajtic; Lei Shi; Jonathan L Katz; Gianluigi Tanda; Amy Hauck Newman
Journal:  Biol Psychiatry       Date:  2012-04-25       Impact factor: 13.382

6.  Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.

Authors:  Carmela M Reichel; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

7.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

8.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

9.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Jean Logan; David Alexoff; Wei Zhu; Frank Telang; Gene-Jack Wang; Millard Jayne; Jacob M Hooker; Christopher Wong; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog-Torres
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272

10.  Modafinil does not serve as a reinforcer in cocaine abusers.

Authors:  Suzanne K Vosburg; Carl L Hart; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2009-09-23       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.